Plasma transferable inhibition of BCG induced subcutaneous inflammation in human cancer
- 1 March 1981
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 133 (3) , 215-227
- https://doi.org/10.1002/path.1711330305
Abstract
When a small dacron sponge disc containing live BCG was implanted subcutaneously in healthy subjects it became infiltrated with leukocytes which at 24 hours mainly involved neutrophils. This mycobacterial-induced inflammatory response was markedly impaired in patients with cancer. This inhibitory effect could be reproduced by injecting the plasma of these patients into guinea-pigs bearing identical discs. The differences in inflammatory reactions in the indirect technique were less marked than in the direct test, though a parallelism between the two was seen. The fact that the plasma from cancer patients interferes with neutrophil responses in this way does not exclude the possibility that abnormal cellular functions were also operative. Since tumour growth control depends on effective inflammation these data further underline the importance in cancer patients of a defect at this level.This publication has 28 references indexed in Scilit:
- Monocyte function in cancer patientsPublished by Elsevier ,1977
- THE SIGNIFICANCE OF MACROPHAGES IN HUMAN AND EXPERIMENTAL TUMORS*Annals of the New York Academy of Sciences, 1976
- Activated macrophages release a factor which lyses malignant cells but not normal cells.The Journal of Experimental Medicine, 1975
- Antileukotactic properties of tumor cells.Journal of Clinical Investigation, 1975
- Immunogenetic Aspects of Implantation, Placentation and Feto-Placental Growth RatesBiology of Reproduction, 1975
- Serum Migration-Inhibitory Activity in Patients with Lymphoproliferative DiseasesNew England Journal of Medicine, 1974
- Migration-Inhibitory Effect of Serum from Patients with Prostatic CancerOncology, 1974
- Migration-Inhibiting Effect of Sera From Patients With Burkitt's Lymphoma 2JNCI Journal of the National Cancer Institute, 1973
- Chemotactic Factor Inactivator in Normal Human SerumJournal of Clinical Investigation, 1973
- Impaired immunologic reactivity and recurrence following cancer surgeryCancer, 1970